FLORIDA / NEW YORK

561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer